Background：Since December 2019, Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)-infected disease (Coronavirus Disease 2019，COVID-19) emerged in Wuhan , China，and rapidly spread throughout China，even throughout the world.
Introduction
In December 2019, a group of acute respiratory diseases with unknown causes[1], now known as Coronavirus Disease 2019 , caused by Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) [2] [3] [4] ,occurred in Wuhan, Hubei Province, China. The 2019 novel coronavirus (2019-nCoV) was declared a Public Health Emergency of International Concern ( PHEIC) by the world health organization on January 30, 2020 [5] ,.The disease has spread rapidly from Wuhan to all over China and other countries [5] [6] [7] [8] [9] .In China(excluding Hong Kong, Macao and Taiwan)，As of 24:00 on February 14, 2020, 66492 confirmed cases have been reported, 8096 discharged cases have been cured and 1523 deaths have been reported [10] .
Despite the rapid spread worldwide，the clinical characteristics of COVID-19 remain largely unclear. Recently, a series of studies have reported the epidemiological and clinical characteristics of patients with .In three recent studies documenting the clinical manifestations of 41、99and138 patients respectively with laboratory-confirmed COVID-19 who were admitted to Wuhan, the severity of some cases with COVID-19 mimicked that of severe acute respiratory syndrome coronavirus (SARS-Cov) [[1，11-12] .Recently, a large sample study recorded data of 1099 laboratory confirmed cases, According to the researchers [13] 《 Diagnosis and treatment of novel coronavirus pneumonia (trial version fifth)》 [17] . Laboratory confirmation of the SARS-CoV-2 was achieved through the Chongqing Wanzhou Center for Disease Control and Prevention.
Data Collection
The internal medicine research group of the Chongqing University Three Gorges Hospital analyzed the patient's medical records. Epidemiological, clinical, laboratory and radiologic characteristics, as well as treatment and outcome data are obtained through electronic medical records. The data were collected and reviewed by a team of trained doctors. The recorded information includes demographic data, medical history, exposure history, potential comorbidities, symptoms, physical signs, laboratory test results (including blood cell analysis, liver and kidney function, coagulation test, C-reactive protein, procalcitonin, lactate dehydrogenase, creatine kinase，Interleukin 6 and urine routine, etc.), chest computed tomography (CT) and treatment measures (i.e. antiviral treatment, corticosteroid treatment, respiratory support, traditional Chinese medicine treatment, nutritional support, etc. 
Statistical analysis
Continuous variables were expressed as the medians and interquartile ranges (IQR) as appropriate. Categorical variables were summarized as the counts and percentages in each category. Means for continuous variables were compared using independent group t tests when the data were normally distributed; otherwise, the Mann-Whitney test was used. Proportions for categorical variables were compared using the χ 2 test, although the Fisher exact test was used when the data were limited.
All statistical analyses were performed using SPSS (Statistical Package for the Social Sciences) version 19.0 software (SPSS Inc). For unadjusted comparisons, a 2-sided α of less than 0.05 was considered statistically significant. The analyses have not been adjusted for multiple comparisons and, given the potential for type I error, the findings should be interpreted as exploratory and descriptive.
Results

General baseline data
The median age of 51 inpatients with COVID-19 was 45 years (interquartile range, 34-51; range, 16-68 years) , including 32 males (62.7%) and 19 females (37.3%); There were 8 cases (15.7%) with comorbidities, 4 cases (7.8%) with diabetes, 4 cases (7.8%) with hypertension, 1 case (2.0%) with diabetes and hypertension, 1 case (2.0%) with chronic hepatitis B and 1 case (2.0%) with schizophrenia (Table 1) .
Of the 51 patients, 44 (86.3%) were non severe (common type), 7 (13.7%) were severe (4 [7.8%] were severe, 3 [5.9%] were critical). author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
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The median time from onset to diagnosis was 6 days (interquartile range, 3-8; range, 1-16 days) in 51 patients.
Clinical characteristics
From onset to diagnosis，the common clinical symptoms were fever in 43 cases (84.3%)；cough in 38 cases (74.5%), Most of them were dry cough with a small amount of expectoration in 16 cases (31.4%); asthenia in 22 cases (43.1%); dyspnea in 11 cases；the other uncommon clinical symptoms were: muscle pain in 6 cases (11.8%); pharyngeal pain in 2 cases (3.9%); nasal obstruction and / or runny nose in 3 cases (5.9%); dizziness in 7 cases (13.7%); headache in 5 cases (9.8%); diarrhea in 4 cases (7.8%); nausea in 3 cases (5.9%); retching or vomiting in 3 cases (5.9%)( Table   1 ). 2 patients (3.9%) developed diarrhea 1-2 days before fever, and 3 patients (5.9%) coughed 1-2 days before fever. Physical examination on admission，16 cases (31.4%) were found to have enlarged breath sounds in both lungs, and 4 cases (7.8%) could hear moist rales in both lungs. Diarrhea occurred in 13 patients (25.5%) during hospitalization. Asthenia, cough, muscle pain and other symptoms disappeared with the recovery of body temperature.
Laboratory test results:
The first day of admission,7 cases (13.7%) had WBC > 9.5 × 109 / L，6 cases (11.8%) had WBC < 3.5 × 109 / L, 11 cases (21.6%) had neutrophil count > 6.3 × 109 / L, 4 cases (7.8%) had neutrophil count < 1.8 × 109 / L, 26 cases (51.0%) had lymphocyte count < 1.1 × 109 / L, 10 cases (19.6%) had platelet count < 125 × 109 / L, 5 cases (9.8%) had AST > 40 U / L, 20 cases (39.2%) had LDH > 250 IU / L, 32 cases (62.7%) had CRP > 5 mg / L, 10 cases (19.6%) had D-dimer > 0.55 mg / L, 25 cases (49.0%) had procalcitonin > 0.046 ng / ml, 16 cases (31.4%) had IL-6 > 5.4pg/ml；8 cases (15.7%) were positive for routine urine protein, and all of them urine red blood cells were negative.
On the first day of admission (n = 51), the laboratory test results (leukocyte count, neutrophil count, lymphocyte count, hemoglobin, platelet, creatine kinase, lactate dehydrogenase, glutamic pyruvate transaminase, glutamic oxaloacetylase, albumin, creatinine, urea nitrogen, C-reactive protein, procalcitonin, interleukin-6) are shown in Table 2 . There are many differences in laboratory test results between severe patients and non-severe patients (Table 2) , including the significant decrease of lymphocyte count, the decrease of serum albumin level, and the significant increase of LDH, CRP, D-dimer and PCT levels.
The results of laboratory test results of patients on the first day of admission (n = 50) and before discharge (n = 50) are compared (Table 3 ). We found that lymphocyte ( L), PLT, CK, LDH and CRP of patients before discharge were significantly increased, while CK, LDH and CRP were significantly reduced (Table 3) .
Imaging examination
51 cases of chest CT were abnormal at the time of admission. During the course of the disease, chest CT mostly showed multiple patchy, flocculent fuzzy shadows, ground glass shadows or high-density shadows, some of which were consolidation;
There were 41 cases of typical ground glass shadow (80.4%), 17 cases of local consolidation of pneumonia (33.3%), 20 cases of pleural thickening (39.2%), 7 cases of small amount of pleural effusion (13.7%), 8 cases of streak shadow of lung (15.7%), 4 cases of multiple solid nodular shadow (7.8%), 2 cases of air bronchogram (3.9%).2 cases (3.9%) had Single lobe lesions，49 cases (96.1%) had Multiple lobe lesions (   Table 4 ) . In addition to one dead patient, 50 patients were reexamined with chest CT within 2 days before discharge. The lesions increased in 1 case (2%), no significant change in 4 cases (8%), and decreased in 45 cases (90%).
Treatment
According to their clinical manifestations and traditional Chinese medicine(TCM) symptoms, most patients were given antiviral treatment with TCM Decoction (28 [54.9%])；All of them received aerosol inhalation of recombinant human interferon a-1b for injection and oral antiviral therapy with Lopinavir and Ritonavir tablets (51 [100%])， some patients were treated with oseltamivir (7 [13.7%]), and 2 patients (3.9%) were given antiviral therapy with arbidol after discontinuation of Lopinavir In 7 severe patients, 6 patients(85.7%) had obvious appetite decline, and they were given "short peptide enteral nutrition solution, protein component diet, dietary fiber component diet" nutritional support treatment; in 7 severe patients, 4 patients (57.1%) were given human albumin infusion treatment, 4 patients (57.1%) were given immunoglobulin treatment (Table 5) . Except one patient died, the remaining 50 patients were discharged according to the discharge standard, the common clinical symptoms disappeared basically, the lymphocyte increased significantly (P =0.008), CRP decreased significantly (P <0.001). The median length of stay was 12 days (IQR, (9) (10) (11) (12) (13) .
Comparison of clinical characteristics between severe patients and non-severe patients
Discussion
This study is a series of patients who have been discharged from non-Wuhan area. As of February 11, 2020, a total of 51 patients were discharged from the single center of the Chongqing University Three Gorges Hospital, of which 50 were cured and discharged, and 1 critically Patients was died. Among the 51 patients in this study, the median number of days from onset to Confirmed diagnosis of COVID-19 was 6 days (IQR, 3-8 days); among the 50 patients who were discharged alive, the Average hospitalization day was 12 days (IQR , 9-13 days).
Most patients had visited Wuhan or other Hubei areas or had close contact with COVID-19 patients within 14 days before the onset of the disease, but 4 cases had no clear epidemiological history of COVID-19 patients, which indicates that there may be active SARS-CoV-2 transmission. The rapid spread of close contact between people is an important feature of , which requires close monitoring to prevent further large-scale spread of SARS-CoV-2 worldwide. The 51 infected people were mainly young adults, mostly imported cases, which may be related to large-scale population migration during the Chinese New Year.
The more common clinical symptoms in this group of cases are: fever 43 ( 84.3%) , cough 38 ( 74.5%) and fatigue 22 (43.1%). However, a small proportion of patients initially did not feel obvious fever, atypical Symptoms, such as diarrhea and nausea and retching, are similar to Professor Zhong Nanshan's study [13] .One patient in this group Without any discomfort and clinical symptoms, was Be hospitalized for a history of epidemiology.
On the first day of admission, the decrease of lymphocyte count was more common (26 [51.0%]); the majority of leukocytes and neutrophils were in the normal range; most patients (32 [62.7%]) had an increase of CRP; some patients had an increase of LDH (20 [39.2%]), D-dimer (10 [19.6%]), ) and PCT (25 [49%]); and urine routine urine protein was positive in 8 cases. Compared with the non-severe patients, the lymphocyte count decreased more significantly in the severe patients, the serum albumin level was lower, and the LDH, CRP, D-dimer and PCT levels were significantly higher. Compared with the results of various laboratory indexes of patients on the first day of admission (N=50) and before discharge (N=50), we found that the lymphocyte and PLT of patients before discharge increased significantly, while CK, LDH and CRP decreased significantly.
Therefore, we speculate that a decrease in lymphocyte count and an increase in Compared with non-severe patients (n = 44), severe patients (n = 7) were older (median age, 52 years vs 44 years), with a higher proportion of diabetes mellitus (4 [57.1%] vs 0 [0.0%])；This suggests that age and comorbid diabetes may be an important factor affecting the patient's condition and prognosis, which was also confirmed by Wei J's study [12] . In this study, only one critically ill patient (dead patient) needs invasive mechanical ventilation, which is lower than previous studies in Wuhan [1, 12] . Due to the shortage of early medical resources in Wuhan [13, 14] , this may be related to the serious condition of inpatients in Wuhan.
This study has several limitations. First, the sample size is small, especially in severe patients. Second, the majority of discharged patients are non-severe patients.
Severe and critically ill patients often have more complications and may require longer hospital stays. Most are still in hospital. Third, there are four COVID-19 treatment centers in Chongqing, and there is still no relevant comparative analysis.
Conclusions
In the case analysis of 51 discharged patients of COVID-19 in the single center of Northeast Chongqing, most of the infected patients were young and middle-aged, All data are presented as medians (interquartile ranges, IQR).Laboratory indicator unit：HB g/l, CK U/L,LDH IU/L,AST U/L,ALT U/L,ALB g/l, Scr umol/l, BUN mmol/l, WBC 10 9 /L,N 10 9 /L,L 10 9 /L,PLT 10 9 /L,CRP mg/l, PCT ng/ml,IL-6 pg/ml, D-D mg/l. P<0.05 was considered statistically significant. Hormone(iv) 10(19.6) 3(6.8) 4(57.1) <0.001
Human albumin (iv) 4(7.8) 0(0) 4(57.1) <0.001 immunoglobulin(iv) 4(7.8) 0(0) 4(57.1) <0.001
High-flow oxygen 8(15.7) 2(4.5) 6(85.7) <0.001 noninvasive ventilation 6(11.8) 0(0) 6(85.7) <0.001
Invasive ventilation 1(2.0) 0(0) 1(14.3) 0.137
Comment：All data are presented as N0.(%). P values denoted the comparison between non-severe cases and severe cases. P<0.05 was considered statistically significant.
